default author photo

Richard D. DiMarchi

Indiana University - Department of Chemistry

United States

Indiana University

107 S Indiana Ave

100 South Woodlawn

Bloomington, IN 47405

United States

Novo Nordisk - Global Research

Måløv

Denmark

Indiana University

107 S Indiana Ave

100 South Woodlawn

Bloomington, IN 47405

United States

SCHOLARLY PAPERS

2

DOWNLOADS

102

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

The Glucose-Dependent Insulinotropic Polypeptide (GIP) Regulates Body Weight and Food Intake Via CNS-GIPR Signaling

Number of pages: 33 Posted: 05 Aug 2020
Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Institute of Food, Nutrition and Health, Department of Health Sciences and Technology (D-HEST), ETH Zürich, Cardiometabolic Diseases Research Department, Boehringer Ingelheim Pharma GmbH, German Center for Diabetes Research (DZD), Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Helmholtz Association of German Research Centres - Research Unit Analytical Pathology, German Research Center for Environmental Health - Institute for Diabetes and Obesity, Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Center for Diabetes Research (DZD), Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Novo Nordisk Research Center Indianapolis, Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Center for Diabetes Research (DZD), Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Cardiometabolic Diseases Research Department, Boehringer Ingelheim Pharma GmbH, Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Center for Diabetes Research (DZD), Novo Nordisk Research Center Indianapolis, Research Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Department of Pharmacology and Systems Physiology, University of Cincinnati-College of Medicine, German Center for Diabetes Research (DZD), Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Indiana University - Department of Chemistry, German Research Center for Environmental Health - Institute for Diabetes and Obesity, Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, Novo Nordisk Research Center Indianapolis, ETH Zürich - Institute of Food, Nutrition and Health and German Research Center for Environmental Health - Institute for Diabetes and Obesity
Downloads 57 (989,921)
Citation 2

Abstract:

Loading...

GIP, food intake, diet-induced obesity, type-2 diabetes, CNS

2.

Efficacy of a Glucagon-Like Peptide-1 and Estrogen Dual Agonist in Pancreatic Islets Protection and Pre-Clinical Models of Insulin-Deficient Diabetes

Number of pages: 36 Posted: 14 Jan 2022
Tulane University - School of Medicine, Tulane University - Section of Endocrinology and Metabolism, Tulane University - Section of Endocrinology and Metabolism, Tulane University - School of Medicine, Tulane University - School of Medicine, Northwestern University, Northwestern University, Novo Nordisk - Global Research, Novo Nordisk - Global Research, Indiana University - Department of Chemistry and Tulane University - Section of Endocrinology and Metabolism
Downloads 45 (1,121,190)

Abstract:

Loading...

GLP-1, estrogen, peptides, dual agonist, diabetes, islet, β cell, Proteomics, RPPA